Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979
Report date:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Version / remarks:
The study was conducted before a guideline was adopted.
Principles of method if other than guideline:
Two groups of male rats (n = 10) received a single treatment of 3100 or 5000 mg/kg bw orally by gavage. Animals were observed for 14 days after treatment. Mortalities and clinical signs were recorded.
GLP compliance:
no
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
p-anisic acid
EC Number:
202-818-5
EC Name:
p-anisic acid
Cas Number:
100-09-4
Molecular formula:
C8H8O3
IUPAC Name:
4-methoxybenzoic acid

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Winkelmann, Borchen, Germany
- Weight at study initiation: 160 - 180 g
- Housing: 5 animals/cage

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
peanut oil
Doses:
3100 and 5000 mg/kg bw
No. of animals per sex per dose:
10
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days

Results and discussion

Effect levels
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Mortality:
At 5000 mg/kg bw two animals died on day 4. No mortalities occurred at 3100 mg/kg bw.
Clinical signs:
At 5000 mg/kg all animals showed clinical signs (diarhoea and increased diuresis). No clinical signs were noted at 3100 mg/kg bw.
Body weight:
no data available
Gross pathology:
no data available

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In this study conducted prior to implementation of current guidelines in male rats an LD50 of > 5000 mg/kg bw was derived.